The new era of OSA management: data, devices, and drugs
DAY 1
Chaired by: Dr Swapna Mandal (London) and Dr Prina Ruparelia (London)
4.30pm - Mild OSA: navigating the grey
Professor Brendan Cooper (Birmingham)
5.00pm - Pharmacological awakening: the rise of drug-based therapies in OSA
Dr Chris Turnbull (Oxford)
5.30pm - Service delivery and practical aspects/local solutions
Dr Sonya Craig (Liverpool)
Gavin Phillips (Liverpool)
4:30 PM
90 MINUTE SESSION
Learning outcomes
Understand the latest evidence linking obstructive sleep apnoea to cardiovascular morbidity and mortality and the impact of treatment.
Gain insights into the challenges and options when managing patients with milder obstructive sleep apnoea, where a more nuanced and holistic approach is often required.
Evaluate pharmacological approaches to OSA management including weight loss agents, noradrenergic agents
Curriculum mapping
Managing patients with sleep disordered breathing and metabolic syndrome
Managing integrated respiratory medicine across the primary and secondary care interface including management of long-term disease
Managing the use of drugs and therapeutic modalities specific to the practice of respiratory medicine